🤝 StartUp Health company Spect Inc. was selected as DocGo’s preferred solution primarily due to its ease of use, ability to integrate seamlessly into clinical workflows, minimal training curve, and availability of a remote Spect specialist to help facilitate the exam. Spect’s platform identifies diabetic retinopathy as well as numerous other eye diseases, such as glaucoma and macular degeneration. #HealthTransformer #HealthMoonshot #diabetes Read more on the partnership ⤵️ https://ow.ly/fp0w50SyiPS
Congratulations Spect Inc. and DocGo! This is a great way to bridge the healthcare gap through mobile services that bring care directly to patients. The increase in access through reduced travel burden ensures everyone receives timely, quality healthcare, leading to healthier, more equitable communities.
Exciting times!
We're excited to bring dilated diabetic retinopathy eye screenings to patients anywhere, especially to those at home!